
Cutera CUTR
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Cutera DSO 2011-2026 | CUTR
DSO Jährlich Cutera
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 327 | 209 | 42.1 | 53.8 | 43.3 | 44 | 50.1 | 51.2 | 44.9 | 52 | 47.4 | 41.8 | 31.4 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 327 | 31.4 | 79.8 |
DSO Vierteljährlich Cutera
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95 | 103 | - | 101 | 77.7 | 81.1 | - | 49.4 | 46.4 | 50.8 | - | 45 | 39 | 42.4 | 40.1 | 51.2 | 76 | 61.6 | 38 | 42.6 | 41.2 | 52.2 | 39.4 | 44.2 | 42.1 | 54 | 39.8 | 49.7 | 52.1 | 58.1 | 39.9 | 49.9 | 55 | 57.4 | 35.4 | 46.1 | 47.2 | 54.6 | 39.9 | 54.3 | 57.3 | 58.7 | 39.7 | 52.5 | 45.1 | 52.9 | 35.8 | 41.5 | 41.2 | 40.7 | 25.6 | 31.1 | 31.8 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 103 | 25.6 | 50.9 |
DSO anderer Aktien in der Medizinische Geräte
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AxoGen
AXGN
|
40.7 | $ 32.86 | 6.03 % | $ 1.51 B | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
43.8 | $ 12.27 | 2.72 % | $ 1.66 B | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
ClearPoint Neuro
CLPT
|
55.6 | $ 9.35 | 3.03 % | $ 265 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 38.24 | 4.28 % | $ 5.7 K | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
FONAR Corporation
FONR
|
237 | $ 18.6 | 0.11 % | $ 122 M | ||
|
Electromed
ELMD
|
137 | $ 24.35 | 2.66 % | $ 206 M | ||
|
Globus Medical
GMED
|
76.8 | $ 91.94 | 2.11 % | $ 12.4 B | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.41 | 0.39 % | $ 128 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
Helius Medical Technologies
HSDT
|
53.3 | $ 1.87 | 2.19 % | $ 1.14 M | ||
|
Align Technology
ALGN
|
86.7 | $ 178.43 | 6.92 % | $ 13.4 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 9.87 | 5.79 % | $ 760 M | ||
|
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
Integer Holdings Corporation
ITGR
|
58.2 | $ 87.61 | 2.89 % | $ 3.04 B | ||
|
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 16.26 | 3.17 % | $ 381 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
LivaNova PLC
LIVN
|
53.8 | $ 64.89 | 2.13 % | $ 3.54 B | ||
|
LENSAR
LNSR
|
38.9 | $ 5.66 | 0.44 % | $ 67.7 M | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Medtronic PLC
MDT
|
68.8 | $ 87.87 | 1.64 % | $ 113 B | ||
|
Butterfly Network
BFLY
|
76.1 | $ 4.11 | 1.23 % | $ 870 M | ||
|
Myomo
MYO
|
35.3 | $ 0.68 | 0.4 % | $ 28.5 M | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Nevro Corp.
NVRO
|
67.6 | - | - | $ 217 M | ||
|
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.64 | 4.92 % | $ 39.8 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
48.5 | $ 9.85 | 1.89 % | $ 353 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 62.39 | 0.87 % | $ 92.4 B | ||
|
Alphatec Holdings
ATEC
|
43.1 | $ 11.51 | 4.31 % | $ 1.73 B | ||
|
IRIDEX Corporation
IRIX
|
47.5 | $ 1.09 | 5.83 % | $ 18.5 M | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 36.73 | 6.25 % | $ 1.14 B |